Mesenchymal Stem-Cell-Derived Exosomes and MicroRNAs: Advancing Cell-Free Therapy in Systemic Sclerosis
Mesenchymal stem cell (MSC) transplantation has emerged as a potential therapeutic strategy for systemic sclerosis (SSc), a rare autoimmune disease characterized by inflammation, fibrosis, and vasculopathy. Recent evidence suggests that the therapeutic benefits of MSCs do not depend directly on thei...
Saved in:
Main Authors: | Cristiano Barbetta, Francesco Bonomi, Gemma Lepri, Daniel E. Furst, Silvia Bellando Randone, Serena Guiducci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/13/1018 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exosomal long noncoding RNAs and microRNAs in colorectal cancer
by: Yun Yen, et al.
Published: (2025-07-01) -
Translating Exosomal microRNAs from Bench to Bedside in Parkinson’s Disease
by: Oscar Arias-Carrión, et al.
Published: (2025-07-01) -
RNA signaling in skeletal muscle: the central role of microRNAs and exosomal microRNAs
by: Shunshun Liu, et al.
Published: (2025-08-01) -
MicroRNAs and type 2 diabetes
by: Jiali Deng, et al.
Published: (2019-06-01) -
Emerging role of extracellular microRNAs and lncRNAs
by: Geyu Zhou, et al.
Published: (2019-03-01)